Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-06-10
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 40
- Registration Number
- NCT00694317
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-06-10
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 39
- Registration Number
- NCT00694187
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00673088
A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 29
- Registration Number
- NCT00674310
Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-02-19
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 52
- Registration Number
- NCT00618228
- Locations
- ๐บ๐ธ
Novum Pharmaceuticals Research Services, Houston, Texas, United States
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-02-19
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 52
- Registration Number
- NCT00618202
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-02-19
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 32
- Registration Number
- NCT00618254
- Locations
- ๐บ๐ธ
MDS Pharma Services, Lincoln, Nebraska, United States
Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00618059
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, LLC, Austin, Texas, United States
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed Conditions
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 32
- Registration Number
- NCT00618111
- Locations
- ๐บ๐ธ
MDS Pharma Services, Lincoln, Nebraska, United States
Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 47
- Registration Number
- NCT00618163
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath